GENINUS Inc. (KOSDAQ:389030)
South Korea · Delayed Price · Currency is KRW 4,705.00
-175.00 (-3.59%)
At close: Apr 9, 2026
GENINUS Market Cap
GENINUS has a market cap or net worth of 157.23 billion as of April 10, 2026. Its market cap has increased by 258.50% in one year.
Market Cap
157.23B
Enterprise Value
152.74B
Revenue
10.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,705.00
Market Cap Chart
Since November 8, 2021, GENINUS's market cap has increased from 145.65B to 157.23B, an increase of 7.95%. That is a compound annual growth rate of 1.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 157.23B | 34.69% |
| Dec 30, 2025 | 116.73B | 154.55% |
| Dec 30, 2024 | 45.86B | -47.60% |
| Dec 28, 2023 | 87.52B | 25.13% |
| Dec 29, 2022 | 69.94B | -49.53% |
| Dec 30, 2021 | 138.58B | -4.85% |
| Nov 8, 2021 | 145.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 456.71B |
| 3billion | 380.50B |
| HLB Panagene | 103.90B |
| Cytogen | 91.82B |
| Green Cross Medical Science | 78.81B |
| Protia | 58.40B |
| Seoulin Bioscience | 53.49B |
| GeneMatrix | 38.73B |